69,807 results on '"BACTEREMIA"'
Search Results
2. 'Salmonella' bloodstream infections
3. The epidemiological, clinical, and microbiological features of patients with 'Burkholderia pseudomallei' bacteraemia implications for clinical management
4. Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)
5. Recurrent Campylobacter Bacteraemia in Immunocompromised Patients (CABARET)
6. Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients With Enterobacterales Bacteremia (MHR-Blood)
7. Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
8. An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures
9. Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)
10. Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient (OCEANIS)
11. Mortality of MBL-producing Enterobacteriaceae Bacteremias With the Combined Use of Ceftazidime-avibactam and Aztreonam vs. Other Active Antibiotics. A Multicenter Target Trial Emulation.
12. A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
13. BALANCE+ Vanguard Phase (BALANCE+)
14. Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation (ARO-DECAMP)
15. Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
16. Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use (AIM-STOP)
17. Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
18. PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections (SPICE-M)
19. Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii (CASCADE)
20. Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia (PHENOTECH-1)
21. Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis (NANO-RAST)
22. Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia (EVOS)
23. Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)
24. Antimicrobial use practices in canine and feline patients with co-morbidities undergoing dental procedures in primary care practices in the US.
25. Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia.
26. Endogenous bacteremia caused by intestinal colonization of Carbapenem-Resistant 'Enterobacteriaceae' (CRE) in immunocompromised children
27. Community-acquired, bacteraemic 'Acinetobacter' Baumannii pneumonia: A retrospective review of cases in tropical Queensland, Australia
28. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan
29. NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification (BIOARTE)
30. Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial (GOAT)
31. Staphylococcus Aureus Network Adaptive Platform Trial (SNAP)
32. Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis (UniEndo)
33. Increasing Insulin Resistance as a Predictor of Impending Bacteremia
34. Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria (ANTHEM)
35. Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial (FAST)
36. Design of a Predictive Score for Contamination of Pediatric Blood Cultures (HEPIC)
37. Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis
38. Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections (OPTIMISE)
39. Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia (SHORTEN2)
40. How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care (PROBIty)
41. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE)
42. PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) (PETERPEN)
43. Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection (CSM-BSI)
44. Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) (VANCAPP)
45. Staphylococcus Aureus Bacteraemia (SAB)-Support-Study (SABOT)
46. Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
47. DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
48. the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in Malignant Effusions.
49. Risk Factors of Post-ERCP Sepsis
50. Rapid Antimicrobial Susceptibility Testing With MIC Directly From Positive Blood Cultures With ASTar (RASTA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.